C677T substitution in the methylenetetrahydrofolate reductase gene as a risk factor for venous thrombosis and arterial disease in selected patients

Haematologica

Volumn 84, Issue 9, 1999, Pages 824-828

  Gemmati, Donato ^a   Serino, Maria Luisa ^b   Trivellato, Christian ^b   Fiorini, Sara ^b   Scapoli, Gian Luigi ^b  

^a UNIVERSITY OF FERRARA   (Italy)

^b NONE

Author keywords

Arterial thrombosis; C677T MTHFR mutation; Hyperhomocysteinemia; Vascular risk factors; Venous thrombosis

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); HOMOCYSTEINE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GENE MUTATION; HOMOZYGOSITY; HUMAN; HYPERHOMOCYSTEINEMIA; MAJOR CLINICAL STUDY; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POLYMERASE CHAIN REACTION; RISK FACTOR; THROMBOPHILIA; VEIN THROMBOSIS;

EID: 0032863447     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Clarke R, Daly L, Robinson K, et al. Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med 1991; 324:1149-55.
2. Fermo I, Viganò D'Angelo S, Paroni R, Mazzola G, Calori G, D'Angelo A. Prevalence of moderate hyperhomocysteinemia in patients with early-onset venous and arterial occlusive disease. Ann Intern Med 1995; 123:747-53.
3. Mandel H, Brenner B, Berant M, et al. Coexistence of hereditary homocystinuria and factor V Leiden - effect on thrombosis. N Engl J Med 1996; 334:763-8.
4. Gemmati D, Serino ML, Moratelli S, Mari R, Ballerini G, Scapoli GL. Coexistence of antithrombin deficiency, factor V Leiden and hyperhomocysteinemia in a thrombotic family. Blood Coag Fibrinol 1998; 9:173-6.
5. Sebastio G, Sperandeo MP, Panico M, de Franchis R, Kraus JP, Andria G. The molecular basis of homocystinuria due to cystathionine β-synthase deficiency in an Italian family, and report of four novel mutations. Am J Hum Genet 1995; 56:1324-33.
6. Goyette P, Frosst P, Rosenblatt DS, Rozen R. Seven novel mutations in the methylenetetrahydrofolate reductase gene and genotype/phenotype correlations in severe methylenetetrahydrofolate reductase deficiency. Am J Hum Genet 1995; 56:1052-9.
7. Stampfer MJ, Willett WC. Homocysteine and marginal vitamin deficiency. The importance of adequate vitamin intake. JAMA 1993; 270:2726-7.
8. Frosst P, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995; 10:111-3.
9. Kang SS, Zhou J, Wong PWK, Kowalisyn J, Strokosh G. Intermediate homocysteinemia: a thermolabile variant of methylenetetrahydrofolate reductase. Am J Hum Genet 1988; 43:414-21.
10. Jacques PF, Bostom AG, William RR, et al. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 1996; 93:7-9.
11. Malinow MR, Nieto FJ, Kruger WD, et al. The effects of Folic acid supplementation on plasma total homocysteine are modulated by multivitamin use and methylenetetrahydrofolate reductase genotypes. Arterioscl Thromb Vasc Biol 1997; 17:1157-62.
12. Kang SS, Wong PWK, Susmano A, Sora J, Norusis M, Ruggie N. Thermolabile methylenetetrahydrofolate reductase: an inherited risk factor for coronary artery disease. Am J Hum Genet 1991 ; 48:536-45.
13. Kluijtmans LAJ, van den Heuvel LPWJ, Boers GHJ, et al. Molecular genetic analysis in mild hyperhomocysteinemia: a common mutation in the methylene tetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease. Am J Hum Genet 1996; 58: 35-41.
14. Gemmati D, Previati M, Serino ML, et al. Low folate levels and thermolabile methylenetetrahydrofolate reductase as primary determinant of mild hyperhomocysteinemia in normal and thromboembolic subjects. Arterioscl Thromb Vasc Biol 1999; in press.
15. Arruda VR, von Zuben PM, Chiaparini LC, Annichino-Bizzacchi JM, Costa FF. The mutation Ala677/ÆVal in the methylenetetrahydrofolate reductase gene: a risk factor for arterial disease and venous thrombosis. Thromb Haemost 1997; 77:818-21.
16. Margaglione M, D'Andrea G, d'Addedda M, et al. The methylenetetrahydrofolate reductase TT677 genotype is associated with venous thrombosis independently of coexistence of the FV Leiden and the prothrombin A20210 mutation. Thromb Haemost 1998; 79:907-11.
17. Tosetto A, Missiaglia E, Frezzato M, Rodeghiero F. The VITA project: C677T mutation in the methylenetetrahydrofolate reductase gene and risk of venous thromboembolism. Br J Haematol 1997; 97:804-6.
18. Legnani C, Palareti G, Grauso F, et al. Hyperhomocyst(e)inemia and a common methylenetetrahydrofolate reductase mutation (Ala223Val MTHFR) in patients with inherited thrombophilic coagulation defects. Arterioscl Thromb Vasc Biol 1997; 17:2924-9.
19. van Bockxmeer FM, Mamotte CDS, Vasikaran SD, Taylor RR. Methylene tetrahydrofolate reductase gene and coronary artery disease. Circulation 1997; 95:21-3.
20. Morita H, Taguchi J, Kurihara H, et al. Genetic polymorphism of 5, 10-methylene tetrahydrofolate reductase (MTHFR) as a risk factor for coronary artery disease. Circulation 1997; 95:2032-6.
21. Markus HS, Ali N, Swaminathan R, Sankaralingam A, Molloy J, Powell J. A common polymorphism in the methylenetetrahydrofolate reductase gene, homocysteine and ischemic cerebrovascular disease. Stroke 1997; 28:1739-43.
22. Sacchi E, Tagliabue L, Duca F, Mannucci PM. High frequency of C677T mutation in the methylenetetrahydrofolate reductase (MTHFR) gene in Northern Italy. Thromb Haemost 1997; 78:963-4.
23. Franco RF, Araújo AG, Guerrelro JF, Elion J, Zago MA. Analysis of the 677CÆT mutation of the methylenetetrahydrofolate reductase gene in different ethnic groups. Thromb Haemost 1998; 79:119-21.
24. Hegele RA, Tully C, Young TK, Connelly PW. C677 mutation of methylene tetrahydrofolate reductase and cardiovascular disease in Canadian Inuit. Lancet 1997; 349:1221-2.
25. Austin H, Hooper WC, Dilley A, et al. The prevalence of two genetic traits related to venous thrombosis in Whites and African-Americans. Thromb Res 1997; 86:409-15.
26. McAndrew PE, Brandt JT, Pearl DK, Prior TW. The incidence of the gene for thermolabile methylenetetrahydrofolate reductase in African Americans. Thromb Res 1996; 83:195-8.
27. Gemmati D, Serino ML, Scapoli GL A modified functional global test to measure protein C, protein S activities and the activated protein C resistance phenotype. Thromb Res 1998; 92:141-8.
28. Gemmati D, Serino ML, Mari R, Verzola I, Moratelli S, Ballerini G. Different anticoagulant response to activated protein C (APC test) and to Agkistrodon Contortix Venom (ACV test) in a family with FV-R506Q substitution. Clin Appl Thromb Haemost 1997; 3: 168-73.
29. Ripoll L, Paulin D, Thomas S, Drouet LO. Multiplex PCR-mediated site-directed mutagenesis for one-step determination of factor V Leiden and G20210A transition of the prothrombin gene. Thromb Haemost 1997; 78:960-1.
30. Falcon CR, Cattaneo M, Panzeri D, Martinelli I, Mannucci PM. High prevalence of hyperhomocyst(e)inemia in patients with juvenile venous thrombosis. Arterioscl Thromb 1994; 14:1080-3.
31. Malinow MR. Plasma homocyst(e)ine: a risk factor for arterial occlusive diseases. J Nutr 1996; 126:1238-43.
32. De Stefano V, Chiusolo P, Paciarono K, et al. Prevalence of the 677C to T mutation in the methylenetetrahydrofolate reductase gene in Italian patients with venous thrombotic disease. Thromb Haemost 1998; 79:686-7.
33. Salden A, Keeney S, Hay CRM, Gumming AM. The C677T MTHFR variant and the risk of venous thrombosis. Br J Haematol 1997; 99:472.
34. Cattaneo M, Tsai MY, Bucciarelli P, et al. A common mutation in the methylenetetrahydrofolate reductase gene (C677T) increases the risk for deep vein thrombosis in patients with mutant factor V (factor V:Q506). Arterioscl Thromb Vasc Biol 1997; 17:1662-6.
35. Kluijtmans LAJ, den Heijer M, Reitsma PH, Heil SG, Blom HJ, Rosendaal FR. Thermolabile methylenetetrahydrofolate reductase and factor V Leiden in the risk of deep-vein thrombosis. Thromb Haemost 1998; 79:254-8.
36. Ridker PM, Hennekens CH, Selhub J, Milethic JP, Malinow MR, Stampfer MJ. Interrelation of hyperhomocyst(e)inemia, factor V Leiden, and risk of future venous thromboembolism. Circulation 1997; 95: 1777-82.
37. Reuner KH, Ruf A, Kaps M, Druschky KF, Patscheke H. The mutation C677→T in the methylenetetrahydrofolate reductase gene and stroke. Thromb Haemost 1998; 79:450-1.
38. Wilcken DEL, Wang XL, Sim AS, McCredie RM. Distribution in healthy and coronary populations of the methylenetetrahydrofolate reductase (MTHFR) C677T mutation. Arterioscl Thromb Vasc Biol 1996; 16:878-82